openPR Logo
Press release

Sepsis Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032) | DelveInsight | Vivacelle Bio, Inotrem SA, Enlivex Therapeutics, Tianjin Chasesun Pharma, Basilea Pharma

05-15-2024 05:38 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Sepsis Market is Predicted to Exhibit Remarkable Growth During

The Sepsis Market size was valued approximately USD 2,807 million in 2022 and the report offers an in-depth understanding of the Sepsis, historical and forecasted epidemiology as well as the Sepsis market trends in the 7MM.
DelveInsight's "Sepsis Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Sepsis, historical and forecasted epidemiology as well as the Sepsis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Sepsis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Sepsis Market Forecast [https://www.delveinsight.com/sample-request/sepsis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Some of the key facts of the Sepsis Market Report:

*
Among the 7MM countries Sepsis market size was valued approximately USD 2,807 million in 2022 and is anticipated to grow with a significant CAGR during the study period (2019-2032)

*
In April 2024, Enlivex Therapeutics released favorable top-line results regarding the safety and efficacy of Allocetra, an off-the-shelf cell therapy, from its Phase II clinical trial for sepsis treatment. This placebo-controlled and randomized trial aims to establish the ideal dosage of Allocetra in conjunction with the standard of care for sepsis arising from diverse infections.

*
In January 2024, Matisse Pharmaceuticals has released promising initial findings from the HistoSeps study, which focused on assessing the safety, tolerability, and pharmacokinetics of M6229 for sepsis treatment. This pioneering human trial, carried out at the Amsterdam University Medical Center, included ten severely ill patients and achieved its primary goals. The results indicated favorable safety and tolerability profiles, as well as pharmacokinetics that closely aligned with the dosage administered intravenously over a six-hour period.

*
In 2022, the 7MM documented 3,543,995 cases of sepsis, and projections indicate an anticipated increase by 2032. Among these cases, the United States held the largest share, contributing 55% to the overall sepsis population, amounting to 1,938,855 cases in 2022.

*
In 2022, the combined total of sepsis cases in the EU4 and the UK reached 1,210,184, and there is an anticipated increase by 2032. Among the EU countries, Germany had the highest share in the sepsis population, recording 322,020 cases in 2022.

*
In Japan, there were 394,956 new cases of sepsis reported. The epidemiological data reveals that the incidence in Japan constituted 11% of the overall patient pool in the 7MM in 2022.

*
Key Sepsis Companies: Vivacelle Bio, Inotrem SA, Enlivex Therapeutics, Tianjin Chasesun Pharmaceutical, Basilea Pharmaceutica, Artcline GmbH, Vivacelle Bio, RWTH Aachen University, Novartis, University of New Mexico, and others

*
Key Sepsis Therapies: VBI-S, Nangibotide, Allocetra,16mgKB, Ceftobiprole medocaril, ARTICE, VBI-S, Pentaglobin Registered /Standard of Care, TIN816 70, Angiotensin II, and others

*
The Sepsis epidemiology based on gender analyzed that in the 7MM, the majority of patient pool were males as compared to females whereas in the US female population dominated the Sepsis incident pool

*
The Sepsis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Sepsis pipeline products will significantly revolutionize the Sepsis market dynamics.

Sepsis Overview

Sepsis is a severe and potentially life-threatening condition that occurs when the body's response to an infection leads to systemic inflammation. The immune system's response to infection can sometimes become overactive, triggering widespread inflammation that can result in organ dysfunction or failure.

Get a Free sample for the Sepsis Market Forecast, Size & Share Analysis Report:

https://www.delveinsight.com/report-store/sepsis-market [https://www.delveinsight.com/report-store/sepsis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Sepsis Epidemiology

Sepsis is a potentially life-threatening condition that occurs when the body's response to an infection causes inflammation throughout the body. Normally, the body's immune system releases chemicals into the bloodstream to fight off an infection. However, in sepsis, this immune response triggers widespread inflammation, leading to blood clot formation and reduced blood flow to vital organs, such as the brain, heart, and kidneys.

Sepsis Epidemiology Segmentation:

The Sepsis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:

*
Total Prevalence of Sepsis

*
Prevalent Cases of Sepsis by severity

*
Gender-specific Prevalence of Sepsis

*
Diagnosed Cases of Episodic and Chronic Sepsis

Download the report to understand which factors are driving Sepsis epidemiology trends @ Sepsis Epidemiology Forecast [https://www.delveinsight.com/sample-request/sepsis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Sepsis Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Sepsis market or expected to get launched during the study period. The analysis covers Sepsis market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Sepsis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Sepsis Therapies and Key Companies

*
VBI-S: Vivacelle Bio

*
Nangibotide: Inotrem SA

*
Allocetra: Enlivex Therapeutics

*
16mgKB: Tianjin Chasesun Pharmaceutical

*
Ceftobiprole medocaril: Basilea Pharmaceutica

*
ARTICE: Artcline GmbH

*
VBI-S: Vivacelle Bio

*
Pentaglobin Registered /Standard of Care: RWTH Aachen University

*
TIN816 70: Novartis

*
Angiotensin II: University of New Mexico

Discover more about therapies set to grab major Sepsis market share @ Sepsis Treatment Landscape [https://www.delveinsight.com/sample-request/sepsis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Scope of the Sepsis Market Report

*
Study Period: 2019-2032

*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

*
Key Sepsis Companies: Vivacelle Bio, Inotrem SA, Enlivex Therapeutics,Tianjin Chasesun Pharmaceutical, Basilea Pharmaceutica, Artcline GmbH, Vivacelle Bio, RWTH Aachen University, Novartis, University of New Mexico, and others

*
Key Sepsis Therapies: VBI-S, Nangibotide, Allocetra, 16mgKB, Ceftobiprole medocaril, ARTICE, VBI-S, Pentaglobin Registered /Standard of Care, TIN816 70, Angiotensin II, and others

*
Sepsis Therapeutic Assessment: Sepsis current marketed and Sepsis emerging therapies

*
Sepsis Market Dynamics: Sepsis market drivers and Sepsis market barriers

*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies

*
Sepsis Unmet Needs, KOL's views, Analyst's views, Sepsis Market Access and Reimbursement

To know more about Sepsis companies working in the treatment market, visit @ Sepsis Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/sepsis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Table of Contents

1. Sepsis Market Report Introduction

2. Executive Summary for Sepsis

3. SWOT analysis of Sepsis

4. Sepsis Patient Share (%) Overview at a Glance

5. Sepsis Market Overview at a Glance

6. Sepsis Disease Background and Overview

7. Sepsis Epidemiology and Patient Population

8. Country-Specific Patient Population of Sepsis

9. Sepsis Current Treatment and Medical Practices

10. Sepsis Unmet Needs

11. Sepsis Emerging Therapies

12. Sepsis Market Outlook

13. Country-Wise Sepsis Market Analysis (2019-2032)

14. Sepsis Market Access and Reimbursement of Therapies

15. Sepsis Market Drivers

16. Sepsis Market Barriers

17. Sepsis Appendix

18. Sepsis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=sepsis-market-is-predicted-to-exhibit-remarkable-growth-during-the-forecast-period-20232032-delveinsight-vivacelle-bio-inotrem-sa-enlivex-therapeutics-tianjin-chasesun-pharma-basilea-pharma]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sepsis Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032) | DelveInsight | Vivacelle Bio, Inotrem SA, Enlivex Therapeutics, Tianjin Chasesun Pharma, Basilea Pharma here

News-ID: 3498045 • Views:

More Releases from ABNewswire

Legendary Limousine Launches First-Class Limo Service in Brooklyn, New York
Legendary Limousine Launches First-Class Limo Service in Brooklyn, New York
Legendary Limousine proudly offers premier luxury transportation services in Brooklyn, New York, featuring a fleet of high-end vehicles including stretch limousines, SUVs, and sedans. Our services cater to a variety of needs such as weddings, proms, corporate events, and airport transfers, ensuring comfort, style, and reliability for every occasion. With professional chauffeurs, customizable packages, Legendary Limousine is dedicated to providing an unmatched travel experience. Brooklyn, New York - Legendary Limousine, a
Peer-to-Peer Powerhouse: Albanian Startup Reimagines Car Rentals
Peer-to-Peer Powerhouse: Albanian Startup Reimagines Car Rentals
Car rentals have long been a convenient option for travelers, providing mobility and freedom. However, the traditional car rental model is fraught with challenges. High costs, significant deposits, stringent requirements, and numerous restrictions often make renting a car more of a hassle than a benefit. This is particularly true in Albania and Greece, where the tourism industry is booming, but the car rental experience has not kept pace with travelers'
Al Arabia Elevators Revolutionizes Home Accessibility and Property Value with the Emergence of Residential Elevators
Al Arabia Elevators Revolutionizes Home Accessibility and Property Value with th …
A home elevator installation adds value to the property and sets trends in interior design and architectural decor while making accessibility much easier. The multistory home environment, characteristic of the fast pace of change with demographic arrivals and urbanization, should be an area of serious interest for design and today's urban planning. First, the essay will plunge into the changing elevator scene and related changing traffic patterns in Dubai before
Discover the Perfect Cabin Vacation in Pine Mountain, GA
Discover the Perfect Cabin Vacation in Pine Mountain, GA
Pine Mountain Cabins offers an ideal retreat for those seeking relaxation and adventure. Located on 22 private acres, the cabin features modern amenities and proximity to attractions like Callaway Gardens, F.D.R. State Park, and Wild Animal Safari. Enjoy outdoor activities, local dining, and seasonal beauty year-round. Perfect for family vacations, romantic getaways, or solo trips, Pine Mountain Cabins provide a memorable experience for all guests. Pine Mountain, GA - Experience the

All 5 Releases


More Releases for Sepsis

Global Sepsis Diagnostics Market to witness Significant Growth Given the Increas …
Inkwood Research anticipates that the Global Sepsis Diagnostics Market is evaluated to record a CAGR of 8.06% in terms of revenue during the forecasting years of 2021-2028. "Browse 55 Market Data Tables and 48 Figures spread over 220 Pages, along with an in-depth TOC on the Global Sepsis Diagnostics Market Forecast 2021-2028." REQUEST FREE SAMPLE LINK - https://www.inkwoodresearch.com/reports/sepsis-diagnostics-market/#request-free-sample Sepsis develops due to the body's response to pathogenic microorganisms, within the blood. The increasing
Sepsis Diagnostics Market 2021 | Increasing Neonatal Umbilical Cord Sepsis Cases …
Sepsis Diagnostics Market 2021 Overview: Sepsis Alliance, a non-profit group, sponsored "It's About TIME" in June 2018, a national campaign to increase awareness about rapid diagnosis and illness care. It is expected that such initiatives by different organizations will raise awareness of the disease and increase the demand for its diagnostic solutions. The latest research report, titled “Sepsis Diagnostics Market” Added by Straits Research, provides the reader with a comprehensive overview of the
04-22-2021 | Health & Medicine
Fact.MR
Sepsis Diagnostics Spurring Heightened R&D to Introduce New Solutions to Prevent …
Fact.MR’s revised sepsis diagnostics market study forecasts a healthy growth trajectory for FY 2021-22 and beyond, with the market expected to increase at a CAGR worth around 8% through 2031. Growth prospects were further underpinned amidst the coronavirus pandemic, attributed to the onset of pneumonia-induced sepsis and consequent fatalities. Click HERE to Get Synopsis of the Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=391 According to the report, the market is expected to yield high short-term gains, generating
Sepsis Diagnostics Market
Sepsis Diagnostics Market by Type, Top Key Players, Size, Share, Growth, Trends - Opportunity, Analysis, Forecast 2024 Sepsis Diagnostics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Sepsis Diagnostics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Sepsis Diagnostics manufacturers and is a valuable source of guidance and
Sepsis Diagnostics Market: Opportunities & Challenges
The Global Sepsis Diagnostics Market is estimated to reach USD 613.9 million by 2023 from USD 396.6 billion in 2018, at a CAGR of 9.1% from 2018 to 2023. The sepsis diagnostics market is primarily driven by the rising prevalence of sepsis across the globe. Factors such as the rising geriatric population, growing number of surgical procedures, high incidence of hospital-acquired infections, and the commercialization and availability of a wide variety
Sepsis Diagnostics
Sepsis Diagnostics Market describes its growth, size, share, Forecast and trends to 2025 Sepsis Diagnostics Market Production and Demand Analysis 2019 to 2025 Sepsis Diagnostics Market 2019 Manufacturing Analysis and Development Forecast 2025 Sepsis Diagnostics Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Sepsis Diagnostics Market to Insight By 2025: Top Key Vendors Sepsis is a three-staged syndrome; it starts with systemic infections leading to severe sepsis and ultimately causing sepsis shock,